122 related articles for article (PubMed ID: 10694326)
1. Expression of brx proto-oncogene in normal ovary and in epithelial ovarian neoplasms.
Miller BT; Rubino DM; Driggers PH; Haddad B; Cisar M; Gray K; Segars JH
Am J Obstet Gynecol; 2000 Feb; 182(2):286-95. PubMed ID: 10694326
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Brx, a novel Dbl family member that modulates estrogen receptor action.
Rubino D; Driggers P; Arbit D; Kemp L; Miller B; Coso O; Pagliai K; Gray K; Gutkind S; Segars J
Oncogene; 1998 May; 16(19):2513-26. PubMed ID: 9627117
[TBL] [Abstract][Full Text] [Related]
3. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
[TBL] [Abstract][Full Text] [Related]
4. p16 overexpression: a potential early indicator of transformation in ovarian carcinoma.
Shigemasa K; Hu C; West CM; Clarke J; Parham GP; Parmley TH; Korourian S; Baker VV; O'Brien TJ
J Soc Gynecol Investig; 1997; 4(2):95-102. PubMed ID: 9101469
[TBL] [Abstract][Full Text] [Related]
5. Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary.
Bruening W; Giasson BI; Klein-Szanto AJ; Lee VM; Trojanowski JQ; Godwin AK
Cancer; 2000 May; 88(9):2154-63. PubMed ID: 10813729
[TBL] [Abstract][Full Text] [Related]
6. Expression of the proto-oncoprotein breast cancer nuclear receptor auxiliary factor (Brx) is altered in eutopic endometrium of women with endometriosis.
Hearns-Stokes R; Mayers C; Zahn C; Cruess D; Gustafsson JA; Segars J; Nieman L
Fertil Steril; 2006 Jan; 85(1):63-70. PubMed ID: 16412732
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor alpha (ER-alpha) and beta (ER-beta) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissues.
Brandenberger AW; Tee MK; Jaffe RB
J Clin Endocrinol Metab; 1998 Mar; 83(3):1025-8. PubMed ID: 9506768
[TBL] [Abstract][Full Text] [Related]
8. Expression of the jun family of genes in human ovarian cancer and normal ovarian surface epithelium.
Neyns B; Katesuwanasing ; Vermeij J; Bourgain C; Vandamme B; Amfo K; Lissens W; DeSutter P; Hooghe-Peters E; DeGrève J
Oncogene; 1996 Mar; 12(6):1247-57. PubMed ID: 8649827
[TBL] [Abstract][Full Text] [Related]
9. Marker profile of different phases in the transition of normal human ovarian epithelium to ovarian carcinomas.
van Niekerk CC; Boerman OC; Ramaekers FC; Poels LG
Am J Pathol; 1991 Feb; 138(2):455-63. PubMed ID: 1992770
[TBL] [Abstract][Full Text] [Related]
10. H-RYK, an unusual receptor kinase: isolation and analysis of expression in ovarian cancer.
Wang XC; Katso R; Butler R; Hanby AM; Poulsom R; Jones T; Sheer D; Ganesan TS
Mol Med; 1996 Mar; 2(2):189-203. PubMed ID: 8726462
[TBL] [Abstract][Full Text] [Related]
11. Rho family Guanine nucleotide exchange factor Brx couples extracellular signals to the glucocorticoid signaling system.
Kino T; Souvatzoglou E; Charmandari E; Ichijo T; Driggers P; Mayers C; Alatsatianos A; Manoli I; Westphal H; Chrousos GP; Segars JH
J Biol Chem; 2006 Apr; 281(14):9118-26. PubMed ID: 16469733
[TBL] [Abstract][Full Text] [Related]
12. Wnt signaling in the ovary: identification and compartmentalized expression of wnt-2, wnt-2b, and frizzled-4 mRNAs.
Ricken A; Lochhead P; Kontogiannea M; Farookhi R
Endocrinology; 2002 Jul; 143(7):2741-9. PubMed ID: 12072409
[TBL] [Abstract][Full Text] [Related]
13. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
14. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization.
Ko J; Lee YH; Hwang SY; Lee YS; Shin SM; Hwang JH; Kim J; Kim YW; Jang SW; Ryoo ZY; Kim IK; Namkoong SE; Kim JW
Oncogene; 2003 Jul; 22(30):4679-89. PubMed ID: 12879013
[TBL] [Abstract][Full Text] [Related]
15. Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins-1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries.
el-Roeiy A; Chen X; Roberts VJ; Shimasakai S; Ling N; LeRoith D; Roberts CT; Yen SS
J Clin Endocrinol Metab; 1994 Jun; 78(6):1488-96. PubMed ID: 7515389
[TBL] [Abstract][Full Text] [Related]
16. Transcription factors GATA-4 and GATA-6 and a GATA family cofactor, FOG-2, are expressed in human ovary and sex cord-derived ovarian tumors.
Laitinen MP; Anttonen M; Ketola I; Wilson DB; Ritvos O; Butzow R; Heikinheimo M
J Clin Endocrinol Metab; 2000 Sep; 85(9):3476-83. PubMed ID: 10999851
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples.
Grisaru-Granovsky S; Salah Z; Maoz M; Pruss D; Beller U; Bar-Shavit R
Int J Cancer; 2005 Jan; 113(3):372-8. PubMed ID: 15455382
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor-beta mRNA expression in rat ovary: down-regulation by gonadotropins.
Byers M; Kuiper GG; Gustafsson JA; Park-Sarge OK
Mol Endocrinol; 1997 Feb; 11(2):172-82. PubMed ID: 9013764
[TBL] [Abstract][Full Text] [Related]
19. Expression of heparanase, Mdm2, and erbB2 in ovarian cancer.
Ginath S; Menczer J; Friedmann Y; Aingorn H; Aviv A; Tajima K; Dantes A; Glezerman M; Vlodavsky I; Amsterdam A
Int J Oncol; 2001 Jun; 18(6):1133-44. PubMed ID: 11351242
[TBL] [Abstract][Full Text] [Related]
20. Ht31: the first protein kinase A anchoring protein to integrate protein kinase A and Rho signaling.
Klussmann E; Edemir B; Pepperle B; Tamma G; Henn V; Klauschenz E; Hundsrucker C; Maric K; Rosenthal W
FEBS Lett; 2001 Nov; 507(3):264-8. PubMed ID: 11696353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
